Use of recombinant human chorionic gonadotropin in ovulation induction

By Ludwig M.i.   Doody K.J.   Doody K.M.  

Fertility and Sterility, Vol. 79, Iss. 5, 2003-05 ,pp. : 1051-1059

Elsevier

Access to resources Recommend Favorite

Recombinant or Urinary Human Chorionic Gonadotropin in Ovulation Induction?

By Allahbadia Gautam  

The Journal of Obstetrics and Gynecology of India, Vol. 61, Iss. 6, 2011-12 ,pp. : 621-623

Springer Publishing Company

Access to resources Recommend Favorite

Ovulation induction and risk of endometrial cancer: a pilot study

By Benshushan A.   Paltiel O.   Brzezinski A.   Tanos V.   Barchana M.   Shoshani O.   Gordon L.   Tsur L.   Schenker J.G.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 98, Iss. 1, 2001-09 ,pp. : 53-57

Elsevier

Access to resources Recommend Favorite

Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (''draw-back'' therapy)

By Tahara M.   Matsuoka T.   Yokoi T.   Tasaka K.   Kurachi H.   Murata Y.  

Fertility and Sterility, Vol. 73, Iss. 4, 2000-04 ,pp. : 799-804

Elsevier

Access to resources Recommend Favorite

Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea - a dose-finding study

By Filicori M.   Cognigni G.E.   Taraborrelli S.   Spettoli D.   Ciampaglia W.   Tabarelli de Fatis C.  

Fertility and Sterility, Vol. 72, Iss. 6, 1999-12 ,pp. : 1118-1120

Elsevier

Access to resources Recommend Favorite